智通财经APP讯,浩欧博(688656.SH)发布公告,公司全资子公司湖南浩欧博生物医药有限公司于近日获得2项由湖南省药品监督管理局核准签发的医疗器械注册证,涉及产品:“抗丙氨酰tRNA合成酶(PL-12)抗体检测试剂盒(磁微粒化学发光法)”、“抗苏氨酰tRNA合成酶(PL-7)抗体检测试剂盒(磁微粒化学发光法)”。
智通财经APP讯,浩欧博(688656.SH)发布公告,公司全资子公司湖南浩欧博生物医药有限公司于近日获得2项由湖南省药品监督管理局核准签发的医疗器械注册证,涉及产品:“抗丙氨酰tRNA合成酶(PL-12)抗体检测试剂盒(磁微粒化学发光法)”、“抗苏氨酰tRNA合成酶(PL-7)抗体检测试剂盒(磁微粒化学发光法)”。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.